{
  "slug": "whitelab-genomics",
  "name": "WhiteLab Genomics",
  "yc_id": 26311,
  "batch": "Winter 2022",
  "website": "https://whitelabgx.com",
  "web_data": {
    "web_enrichment_version": "1.0.0",
    "enriched_at": "2025-10-17T01:16:13.902086",
    "website": "https://whitelabgx.com",
    "website_status": {
      "reachable": true,
      "status_code": 200,
      "response_time_ms": 1540.45,
      "final_url": "https://whitelabgx.com/",
      "redirected": true,
      "checked_at": "2025-10-17T01:16:15.442548"
    },
    "ssl_security": {
      "disabled": true,
      "reason": "certificate_verification_failed"
    },
    "domain_info": {
      "domain": "whitelabgx.com",
      "registrar": "GoDaddy.com, LLC",
      "creation_date": "2019-02-07T18:41:00",
      "expiration_date": "2026-02-07T18:41:00",
      "domain_age_days": 2443,
      "domain_age_years": 6.7,
      "name_servers": [
        "NS69.DOMAINCONTROL.COM",
        "NS70.DOMAINCONTROL.COM"
      ]
    },
    "social_links": {
      "twitter": null,
      "linkedin": "https://www.linkedin.com/company/whitelabgenomics",
      "github": null,
      "facebook": null,
      "instagram": null,
      "youtube": null
    },
    "security_headers": {
      "strict_transport_security": true,
      "content_security_policy": true,
      "x_frame_options": true,
      "x_content_type_options": false,
      "x_xss_protection": false,
      "referrer_policy": false,
      "security_score": 50,
      "server": "cloudflare"
    }
  },
  "enrichment_version": "1.0.0",
  "enriched_at": "2025-10-17T10:39:48.428506",
  "phase1_complete": true,
  "phase2_complete": false,
  "phase3_complete": false,
  "phase4_complete": false,
  "phase5_complete": false,
  "ai_insights": {
    "ai_insights_version": "1.0.0-claude",
    "model_used": "claude-sonnet-4-20250514",
    "enriched_at": "2025-10-17T10:52:27.037655",
    "market_analysis": {
      "market_size": "very large",
      "market_stage": "emerging",
      "key_trends": [
        "AI-driven drug discovery acceleration",
        "Personalized genomic medicine growth",
        "Increased investment in gene and cell therapies"
      ]
    },
    "competitive_positioning": {
      "competitive_moat": "Proprietary AI algorithms for genomic therapy design with specialized domain expertise",
      "differentiation": "Focus specifically on DNA/RNA therapy design rather than general drug discovery",
      "competitive_advantages": [
        "Specialized genomic therapy AI platform",
        "Early mover in AI-genomics intersection"
      ],
      "competitive_vulnerabilities": [
        "Large pharma developing in-house AI capabilities",
        "Competition from established biotech AI platforms"
      ]
    },
    "business_model": {
      "revenue_model": "SaaS/licensing",
      "scalability": "high",
      "capital_intensity": "medium"
    },
    "growth_assessment": {
      "growth_stage": "series-a",
      "growth_indicators": [
        "40-person team size indicates scaling",
        "6.7-year domain age shows established presence"
      ],
      "growth_bottlenecks": [
        "Long validation cycles in genomic therapies",
        "Regulatory approval timelines for client products"
      ]
    },
    "risk_analysis": {
      "market_risk": "medium",
      "technology_risk": "high",
      "execution_risk": "medium",
      "overall_risk_score": 7,
      "key_risks": [
        "Regulatory changes in genomic therapies",
        "AI model validation in clinical settings",
        "Competition from tech giants entering healthcare AI"
      ]
    },
    "investment_thesis": {
      "strengths": [
        "Large addressable market in genomic medicine",
        "AI-first approach to complex biological problems",
        "Experienced team with significant headcount"
      ],
      "concerns": [
        "High technical complexity and validation requirements",
        "Long sales cycles with pharmaceutical clients"
      ],
      "exit_potential": "acquisition",
      "comparable_companies": [
        "Recursion Pharmaceuticals",
        "Insitro"
      ]
    },
    "recommendations": {
      "next_steps": [
        "Secure strategic partnerships with major pharma companies",
        "Demonstrate clinical validation of AI-designed therapies"
      ],
      "expansion_opportunities": [
        "Geographic expansion to Asian markets",
        "Adjacent applications in agricultural genomics"
      ]
    },
    "tokens_used": {
      "input": 674,
      "output": 560,
      "total": 1234,
      "estimated_cost": 0.010422
    },
    "status": "success"
  },
  "phase8_complete": true
}